A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Glargine, Both in Combination With Mealtime Insulin, in People With Type 2 Diabetes Who Use Daily Insulin and Mealtime Insulin (ONWARDS 4)
Clinical trial NCT04880850 · COMPLETED
Trial details
- NCT number
- NCT04880850
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-14
- Primary completion
- 2022-06-16
- Enrollment
- 582
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.